Organization · Venture Capital
The Korea-Seoul Life Science Fund (KSLSF)
The Korea-Seoul Life Science Fund (KSLSF) is a cross-border venture capital fund based in Korea, focusing on early-stage investments in the life sciences sector, including biotechnology and medical devices.
Overview
What The Korea-Seoul Life Science Fund (KSLSF) does
What The Korea-Seoul Life Science Fund (KSLSF) is
The Korea-Seoul Life Science Fund (KSLSF) is a cross-border venture capital fund based in Korea, focusing on early-stage investments in the life sciences sector, including biotechnology and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find The Korea-Seoul Life Science Fund (KSLSF) elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Korea-Seoul Life Science Fund (KSLSF) as a funder
Investment thesis
The Korea-Seoul Life Science Fund (KSLSF) focuses on early-stage investments in the life sciences sector, particularly in biotechnology, drugs, medical devices, diagnostics, and healthcare services.
Focus narrative
KSLSF primarily invests in early-stage life science companies, focusing on sectors such as biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services. The fund seeks to identify and support innovative solutions that can transform healthcare and improve patient outcomes.
Value beyond capital
KSLSF adds value to its portfolio companies through strategic partnerships, access to industry expertise, and support in navigating the complexities of the life sciences sector. The fund's connections with government entities and established venture partners enhance its ability to facilitate growth and successful exits for its investments.
Terms and economics
- Typical check
- $2,700,000
Focus and fit
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- Corestem, CrystalGenomics, Kang Stem Biotech, PCL, and PharmAbcine
Portfolio context
Notable portfolio companies include Corestem, a clinical-stage biotech developing adult stem cell therapies; CrystalGenomics, a small molecule drug company; Kang Stem Biotech, specializing in stem cell therapies; PCL, a diagnostics company; and PharmAbcine, which develops therapeutic antibodies for cancer.
Common questions
What to know about The Korea-Seoul Life Science Fund (KSLSF)
Upseed classifies The Korea-Seoul Life Science Fund (KSLSF) under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.